Drug-drug Interactions With Anti-tuberculous Drugs
Recruiting
- Conditions
- Drug-drug Interaction
- Registration Number
- NCT06381375
- Lead Sponsor
- Cairo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Inclusion Criteria:<br><br> - All patients diagnosed with tuberculosis and referred to Tuberculosis outpatient<br> clinic, Kasr Alainy Faculty of Medicine, Cairo University, starting after the<br> obtaining of the Scientific/Ethical approval of the study protocol.<br><br>Exclusion Criteria:<br><br> - Refusal by the patient/patient's guardian to participate in this study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients;2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events).
- Secondary Outcome Measures
Name Time Method